X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3655) 3655
Publication (371) 371
Conference Proceeding (15) 15
Book Chapter (6) 6
Book Review (4) 4
Data Set (2) 2
Magazine Article (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
male (2470) 2470
animals (2243) 2243
neurosciences (1798) 1798
rats (1540) 1540
putamen - metabolism (1474) 1474
humans (1472) 1472
female (1330) 1330
caudate nucleus - metabolism (1012) 1012
index medicus (991) 991
dopamine (840) 840
dopamine - metabolism (839) 839
brain (797) 797
putamen (787) 787
caudate-putamen (762) 762
middle aged (751) 751
adult (669) 669
aged (626) 626
rats, sprague-dawley (609) 609
corpus striatum - metabolism (603) 603
brain - metabolism (588) 588
basal ganglia (574) 574
putamen - drug effects (558) 558
striatum (492) 492
clinical neurology (438) 438
caudate nucleus - drug effects (432) 432
parkinson's disease (432) 432
magnetic resonance imaging (392) 392
neurons (360) 360
psychiatry (353) 353
pharmacology & pharmacy (348) 348
mice (338) 338
nucleus accumbens - metabolism (322) 322
nucleus-accumbens (315) 315
nucleus accumbens (312) 312
putamen - pathology (312) 312
putamen - diagnostic imaging (307) 307
neurology (303) 303
autoradiography (294) 294
corpus striatum - drug effects (293) 293
parkinsons-disease (291) 291
time factors (289) 289
immunohistochemistry (282) 282
parkinson disease - metabolism (279) 279
rats, inbred strains (264) 264
article (262) 262
cortex (261) 261
neurons - metabolism (256) 256
rats, wistar (248) 248
neuroimaging (240) 240
positron emission tomography (239) 239
nervous system (236) 236
substantia nigra - metabolism (236) 236
neostriatum (230) 230
nucleus accumbens - drug effects (228) 228
biochemistry & molecular biology (227) 227
brain - drug effects (226) 226
cocaine (222) 222
rat (211) 211
multidisciplinary sciences (203) 203
dose-response relationship, drug (201) 201
schizophrenia (201) 201
brain mapping (200) 200
receptors, dopamine d2 - metabolism (199) 199
substantia-nigra (199) 199
substantia nigra (198) 198
receptors (193) 193
in-vivo (192) 192
tomography, emission-computed (192) 192
rat-brain (191) 191
aged, 80 and over (188) 188
microdialysis (183) 183
caudate nucleus - diagnostic imaging (181) 181
metabolism (179) 179
analysis (175) 175
disease models, animal (173) 173
neostriatum - metabolism (173) 173
receptors, dopamine - metabolism (171) 171
caudate nucleus (169) 169
cerebral cortex - metabolism (167) 167
dopamine transporter (167) 167
rna, messenger - metabolism (166) 166
caudate putamen (165) 165
medicine (164) 164
pet (159) 159
motor activity - drug effects (158) 158
rodents (157) 157
in vitro techniques (156) 156
kinetics (156) 156
phenols (156) 156
hippocampus (155) 155
brain - pathology (154) 154
neurodegenerative diseases (153) 153
parkinson disease - diagnostic imaging (153) 153
prefrontal cortex (153) 153
research article (153) 153
release (150) 150
putamen - physiology (149) 149
reference values (149) 149
cocaine - pharmacology (148) 148
gene expression (148) 148
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3625) 3625
Japanese (8) 8
French (7) 7
German (7) 7
Spanish (4) 4
Chinese (3) 3
Russian (3) 3
Hungarian (1) 1
Portuguese (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Brain, ISSN 0006-8950, 12/2009, Volume 132, Issue 12, pp. 3285 - 3297
Mitochondrial dysfunction hypothetically contributes to neuronal degeneration in patients with Parkinson's disease. While several in vitro data exist, the... 
P MRS | Energy metabolism | Mitochondrial dysfunction | Parkinson's disease | MR spectroscopy | OXIDATIVE-PHOSPHORYLATION | HUMAN BRAIN | mitochondrial dysfunction | NEUROSCIENCES | P-31 MR SPECTROSCOPY | CLINICAL NEUROLOGY | MULTIPLE SYSTEM ATROPHY | COENZYME Q | IN-VIVO ASSESSMENT | COMPLEX-I | P-31 MRS | PLACEBO-CONTROLLED TRIAL | ENERGY-METABOLISM | energy metabolism | PROGRESSIVE SUPRANUCLEAR PALSY | Protons | Substantia Nigra - physiopathology | Predictive Value of Tests | Humans | Middle Aged | Mitochondrial Diseases - metabolism | Male | Substantia Nigra - metabolism | Brain - metabolism | Brain Diseases, Metabolic - diagnosis | Putamen - physiopathology | Adenosine Triphosphate - metabolism | Female | Parkinson Disease - metabolism | Energy Metabolism - physiology | Biomarkers - metabolism | Magnetic Resonance Spectroscopy - methods | Adenosine Triphosphate - analysis | Brain - physiopathology | Biomarkers - analysis | Oxidative Phosphorylation | Mitochondria - metabolism | Phosphocreatine - analysis | Brain Diseases, Metabolic - metabolism | Parkinson Disease - physiopathology | Disease Progression | Brain Chemistry - physiology | Brain Diseases, Metabolic - physiopathology | Phosphorus - metabolism | Parkinson Disease - diagnosis | Aged | Phosphocreatine - metabolism | Mitochondrial Diseases - physiopathology | Mitochondrial Diseases - diagnosis | Putamen - metabolism
Journal Article
Brain, ISSN 0006-8950, 09/2017, Volume 140, Issue 9, pp. 2460 - 2474
Journal Article
Journal of Neuropathology and Experimental Neurology, ISSN 0022-3069, 10/2009, Volume 68, Issue 10, pp. 1073 - 1083
Journal Article
Neurobiology of Aging, ISSN 0197-4580, 2014, Volume 35, Issue 5, pp. 1111 - 1115
Journal Article
Journal of Comparative Neurology, ISSN 0021-9967, 02/2010, Volume 518, Issue 3, pp. 277 - 291
Journal Article
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 11/2009, Volume 29, Issue 47, pp. 14734 - 14740
Journal Article
Psychopharmacology, ISSN 0033-3158, 3/2018, Volume 235, Issue 3, pp. 737 - 747
Adolescent alcohol exposure may increase depression vulnerability in adulthood by increasing the anhedonic response to stress.Male Wistar rats (postnatal days... 
Binge drinking | Neurosciences | Biomedicine | Ethanol | Corticosterone | Anhedonia | Intracranial self-stimulation | Corticotropin-releasing factor | Pharmacology/Toxicology | Social defeat | Psychiatry | YOUNG-ADULTS | CRHR1 GENE | SOCIAL STRESS | PSYCHIATRY | NEUROSCIENCES | NUCLEUS-ACCUMBENS | CORTICOTROPIN-RELEASING-FACTOR | PROTEIN EXPRESSION | MEDIAL PREFRONTAL CORTEX | PHARMACOLOGY & PHARMACY | INTERMITTENT ETHANOL EXPOSURE | LIFE EVENTS | TONIC INHIBITION | Receptors, Corticotropin-Releasing Hormone - metabolism | Self Stimulation | Rats, Wistar | Alcohol-Related Disorders - psychology | Nucleus Accumbens - metabolism | Rats | Depression | Male | Corticotropin-Releasing Hormone - metabolism | Brain - drug effects | Brain - metabolism | Central Nervous System Depressants - pharmacology | Ethanol - pharmacology | Alcohol-Related Disorders - metabolism | Animals | Prefrontal Cortex - drug effects | Anhedonia - drug effects | Serotonin - metabolism | Stress, Psychological - metabolism | Prefrontal Cortex - metabolism | Glutamic Acid - metabolism | Biogenic Monoamines - metabolism | Reward | Dopamine - metabolism | Psychological aspects | Alcohol and youth | Glutamate | Health aspects | Stresses | Brain | Cortex (prefrontal) | Dopamine | Amygdala | Serotonin | Alcohol | Exposure | mRNA | Mental depression | Metabolism | Corticotropin-releasing hormone | Putamen | Monoamines | Nucleus accumbens | Alterations | Social interactions | Hedonic response | Rodents | Reinforcement | Self-stimulation
Journal Article
Journal Article
Diabetes, ISSN 0012-1797, 2014, Volume 63, Issue 12, pp. 4186 - 4196
Gut-derived hormones, such as GLP-1, have been proposed to relay information to the brain to regulate appetite. GLP-1 receptor agonists, currently used for the... 
HIGH-CALORIE | GLUCAGON-LIKE PEPTIDE-1 | FOOD-INTAKE | GLUCOSE | EXENATIDE | ENDOCRINOLOGY & METABOLISM | ENERGY-INTAKE | OPEN-LABEL | WEIGHT | ORBITOFRONTAL CORTEX | PROMOTES SATIETY | Amygdala - drug effects | Receptors, Glucagon - antagonists & inhibitors | Putamen - physiology | Humans | Middle Aged | Male | Peptide Fragments - pharmacology | Diabetes Mellitus, Type 2 - metabolism | Brain - physiology | Case-Control Studies | Cerebral Cortex - metabolism | Brain - metabolism | Prefrontal Cortex - drug effects | Adult | Female | Appetite - physiology | Cerebral Cortex - drug effects | Receptors, Glucagon - agonists | Amygdala - metabolism | Appetite - drug effects | Putamen - drug effects | Feeding Behavior - physiology | Feeding Behavior - drug effects | Hypoglycemic Agents - pharmacology | Obesity - metabolism | Peptides - pharmacology | Brain - drug effects | Cross-Over Studies | Magnetic Resonance Imaging | Functional Neuroimaging | Glucagon-Like Peptide-1 Receptor | Prefrontal Cortex - metabolism | Cerebral Cortex - physiology | Aged | Venoms - pharmacology | Reward | Photic Stimulation | Amygdala - physiology | Prefrontal Cortex - physiology | Receptors, Glucagon - physiology | Putamen - metabolism | Type 2 diabetes | Care and treatment | Brain research | Analysis | Appetite depressants | Dosage and administration | Glycemic index | Research | Obesity | Brain | Nuclear magnetic resonance--NMR | Diabetes | Hormones | Medical treatment
Journal Article